High transduction efficiency of human amniotic fluid stem cells mediated by adenovirus vectors

Stem Cells and Development

Volumn 17, Issue 5, 2008, Pages 953-962

  Grisafi, Davide ^a   Piccoli, Martina ^a   Pozzobon, Michela ^a   Ditadi, Andrea ^a   Zaramella, Patrizia ^a   Chiandetti, Lino ^a   Zanon, Giovanni Franco ^a   Atala, Anthony ^b   Zacchello, Franco ^a   Scarpa, Maurizio ^a   Coppi, Paolo De ^a,c   Tomanin, Rosella ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b WAKE FOREST UNIVERSITY   (United States)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; ENHANCED GREEN FLUORESCENT PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 4; GREEN FLUORESCENT PROTEIN;

ADIPOCYTE; AMNIOTIC FLUID CELL; AMNIOTIC FLUID STEM CELL; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; OSTEOCYTE; PHENOTYPE; PRIORITY JOURNAL; STEM CELL; ADENOVIRUS; ADENOVIRUS INFECTION; AMNION FLUID; CELL SEPARATION; CYTOLOGY; FLOW CYTOMETRY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; METABOLISM; PREGNANCY; VIROLOGY;

ADENOVIRIDAE;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; AMNIOTIC FLUID; CELL DIFFERENTIATION; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; PREGNANCY; STEM CELLS; TRANSDUCTION, GENETIC;

EID: 58149145663     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.0188     Document Type: Article

References (36)

1. Strauer BE, R Kornowski. (2003). Stem cell therapy in perspective. Circulation 107:929-934.
2. Bongso A, M Richards. (2004). History and perspective of stem cell research. Best Pract Res Clin Obstet Gynaecol 18:827-842.
3. Rohwedel J, K Guan, C Hegert, AM Wobus. (2001). Embryonic stem cells as an in vitro model for mutagenicity, cytotoxicity and embryotoxicity studies: present state and future prospects. Toxicol In Vitro 15:741-753.
4. Pittenger MF, JD Mosca, KR McIntosh. (2000). Human mesenchymal stem cells: progenitor cells for cartilage, bone, fat and stroma. Curr Top Microbiol Immunol. 251:3-11.
5. Zuk PA, M Zhu, P Ashjian, DA De Ugarte, JI Huang, H Mizuno, ZC Alfonso, JK Fraser, P Benhaim, MH Hedrick. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295.
6. De Coppi P, M Pozzobon, M Piccoli, MV Gazzola, L Boldrin, E Slanzi, R Destro, L Zanesco, GF Zanon, P Gamba. (2006). Isolation of mesenchymal stem cells from human vermiform appendix. J Surg Res 135:85-91.
7. Bartsch G, JJ Yoo, P De Coppi, MM Siddiqui, G Schuch, HG Pohl, J Fuhr, L Perin, S Soker, A Atala. (2005). Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitors. Stem Cells Dev 14:337-348.
8. Guillot PV, C Gotherstrom, J Chan, H Kurata, NM Fisk. (2007). Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. STEM CELLS 2007, 25:646-654.
9. In 't Anker PS, SA Scherjon, C Kleijburg-van der Keur, GM de Groot-Swings, FH Claas, WE Fibbe, HH Kanhai. (2004). Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. STEM CELLS 22:1338-1345.
10. Fauza D. (2004). Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol 18:877-891.
11. Sartore S, M Lenzi, A Angelini, A Chiavegato, L Gasparotto, P De Coppi, R Bianco, G Gerosa. (2005). Amniotic mesenchymal cells autotransplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes. Eur J Cardiothorac Surg 28:677-684.
12. De Coppi P, A Callegari, A Chiavegato, L Gasparotto, M Piccoli, J Taiani, M Pozzobon, L Boldrin, M Okabe, E Cozzi, A Atala, P Gamba, S Sartore. (2007). Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol 177:369-376.
13. De Coppi P, G Bartsch, MM Siddiqui, T Xu, CC Santos, L Perin, G Mostoslavsky, AC Serre, EY Snyder, JJ Yoo, ME Furth, S Soker, A Atala. (2007). Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25:100-106.
14. Kawabata K, F Sakurai, N Koizumi, T Hayakawa, H Mizuguchi. (2006). Adenovirus vector-mediated gene transfer into stem cells. Mol Pharm 3:95-103.
15. Egermann M, AW Baltzer, S Adamaszek, C Evans, P Robbins, E Schneider, CA Lill. (2006). Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. Hum Gene Ther 17:507-517.
16. Lin Y, L Liu, Z Li, J Qiao, L Wu, W Tang, X Zheng, X Chen, Z Yan, W Tian. (2006). Pluropotency potential of human adipose-derived stem cells marked with exogenous green fluorescent protein. Mol Cell Biochem 291:1-10.
17. Zachos TA, KM Shields, AL Bertone. (2006). Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6. J Orthop Res 24:1279-1291.
18. Mizuguchi H, T Sasaki, K Kawabata, F Sakurai, T Hayakawa. (2005). Fiber-modified adenovirus vectors mediate efficient gene transfer into undifferentiated and adipogenic- differentiated human mesenchymal stem cells. Biochem Biophys Res Commun 332:1101-1106.
19. Kawabata K, F Sakurai, T Yamaguchi, T Hayakawa, H Mizuguchi. (2005). Efficient gene transfer into mouse embryonic stem cells with adenovirus vectors. Mol Ther 12:547-554.
20. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig, DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
21. Morsy MA, EL Alford, A Bett, FL Graham, CT Caskey. (1993). Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes. J Clin Invest 92:1580-1586.
22. Anton M, IEO Gomaa, T von Lukowicz. (2005). Optimization of radiation controlled gene expression by adenoviral vectors in vitro. Cancer Gene Ther 12:640-646.
23. Graham FL, J Smiley, WC Russell, R Nairn. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59-74.
24. Bosch P, C Fouletier-Dilling, EA Olmsted-Davis, AR Davis, SL Stice. (2006). Efficient adenoviral-mediated gene delivery into porcine mesenchymal stem cells. Mol Reprod Dev 73:1393-1403.
25. Hung SC, CY Lu, SK Shyue, HC Liu, LL Ho. (2004). Lineage differentiation-associated loss of adenoviral susceptibility and Coxsackie-adenovirus receptor expression in human mesenchymal stem cells. Stem Cells 22:1321-1329.
26. Conget PA, JJ Minguell. (2000). Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells. Exp Hematol 28:382-390.
27. Chan J, K O'Donoghue, J de la Fuente, IA Roberts, S Kumar, JE Morgan, NM Fisk. (2005). Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 2005, 23:93-102.
28. Greber UF. (2002). Signalling in viral entry. Cell Mol Life Sci 59:608-626.
29. Chuah MK, D Collen, T VandenDriessche. (2003). Biosafety of adenoviral vectors. Curr Gene Ther 3:527-543.
30. Ng P, FL Graham. (2002). Construction of first-generation adenoviral vectors. Methods Mol Med 69:389-414.
31. Hitt MM, P Ng and FL Graham. (2005). Construction and propagation of human adenovirus vectors. In: Cell Biology: a Laboratory Handbook, 3rd edn. Edited by J. E. Celis. San Diego: Academic Press, Vol. 1, pp. 435-443.
32. Morsy MA, M Gu, S Motzel, J Zhao, J Lin, Q Su, H Allen, L Franlin, RJ Parks, FL Graham, S Kochanek, AJ Bett, CT Caskey. (1998). An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci U S A 95:7866-7871.
33. Maione D, C Della Rocca, P Giannetti, R D'Arrigo, L Liberatoscioli, LL Franlin, V Sandig, G Ciliberto, N La Monica, R Savino. (2001). An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus. Proc Natl Acad Sci U S A 98:5986-5991.
34. Gilbert R, RW Dudley, AB Liu, BJ Petrof, J Nalbantoglu, G Karpati. (2003). Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin. Hum Mol Genet 12:1287-1299.
35. Soifer H, C Higo, CR Logg, LJ Jih, T Shichinohe, E Harboe-Schmidt, K Mitani, N Kasahara. (2002). A novel, helper-dependent, adenovirus-retrovirus hybrid vector: stable transduction by a two-stage mechanism. Mol Ther 5:599-608.
36. Zhang HG, YM Wang, JF Xie, X Liang, HC Hsu, X Zhang, J Douglas, DT Curiel, JD Mountz. (2001). Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus. Gene Ther 8:704-712.